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Abstract 200 words 
 
Purpose of review  
The aim of the review was to explore patient and family caregiver perspectives on key issues 
for ensuring quality of end of life care for people with chronic obstructive pulmonary 
disease (COPD). The growing evidence on the value of specialist palliative care services 
demonstrates significant improvements in treatments and provisions, however, much of the 
literature is generic in nature or centred on people with a cancer diagnosis. In this review 
we examine the literature to ascertain the views and needs of patients and carers affected 
by advanced COPD, a highly debilitating condition that can have a profoundly negative 
impact on the quality of end of life experience. 
Recent findings: 19 papers were included in the review.  The main themes in the literature 
were Holistic Care; Illness Trajectory; and Technology. 
Summary Areas of unmet need emphasised across physical, psychosocial and spiritual 
domains were identified, in particular in relation to appropriate and timely conversations. 
Positive developments in the care and treatment of advanced COPD include the use of the 
STIOLTO Respimat inhaler, a brief educative and psychosocial intervention based on 
cognitive-behavioural therapy, and high intensity exercise training. 
There is some evidence regarding the use of technology in end stage COPD. (198 words) 
Keywords: rapid review, advanced chronic obstructive pulmonary disease (COPD), end of 
life care, palliative care, patient and carer preferences 
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Introduction  
 
The World Health Organisation defines palliative care  as, “an approach that improves the 
quality of life of patients and their families facing the problem associated with life-
threatening illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other problems, 
physical, psychosocial and spiritual" 1. Palliative and end of life care globally is now 
considered a human right 2 and quality of life, care and death of people at the end of life is a 
growing public priority 3-5. Yet, there are major gaps in the evidence regarding preference of 
death and factors influencing these in the area of non-malignant life limiting conditions6. 
 
Chronic obstructive pulmonary disease (COPD) is a debilitating, progressive condition that is 
the fourth leading cause of death worldwide, claiming 3.2 million lives in 20157. COPD is 
linked to multiple morbidity and symptoms such as cough, phlegm, breathlessness, 
discomfort, fatigue and acute exacerbations of the disease which can intensify respiratory 
symptoms8. It is diagnosed through spirometry. The presence of a post-bronchodilator 
FEV1/FVC of < 0.70 confirms the presence of persistent airflow limitation9. The disease, 
however, frequently remains undiagnosed until people have reached the moderate or 
severe stages of the disease trajectory by which time their quality of life is usually 
impeded10.  
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Although, in recent years, there have been noteworthy advances in the treatment for 
people living with chronic respiratory disease, curative treatment for advanced COPD is 
unlikely and life expectancy remains poor 10.The extreme breathlessness associated with 
COPD can lead to rapid and major decline in physical capacity and affect the psychological 
integrity of patients11. Other factors that may intensify the experience of living with this 
illness are economic issues and the presence of financial hardship12.  Family carers are often 
central support providers, helping people live with and manage the condition but challenges 
and responsibilities around treatment and care decision-making can bring additional 
stressors on top of dealing with everyday life.  Despite an expressed desire of patients and 
family/informal carers to engage in discussions around end of life care, there is little 
evidence to suggest that the occurrence of such dialogue is commonplace within the 
context of COPD 13, 14. Moreover, people with advanced COPD worldwide often have 
difficulty accessing specialist palliative care services due to the variable trajectory and 
episodic breathlessness15. 
 
The aim of the review was to scope information available from recently published empirical 
research to explore patient and family caregiver perspectives on key issues for ensuring 
quality of end of life care for people with chronic obstructive pulmonary disease (COPD).  
We were primarily concerned with advanced/severe COPD and in people with a prognosis of 
one year or less, where that was possible to determine.  
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Methods of review 
A rapid review of the literature was undertaken to explore key issues pertaining to quality in 
end of life care for people with COPD. A protocol was developed and agreed prior to starting 
the review which followed similar processes to that of a full systematic review but limiting 
the scope of the search by reducing the number of databases searched, excluding grey 
literature searching and placing limitations on search terms and eligible dates (see Appendix 
I). The search strategy was designed using a keyword search of articles related to the theme 
to identify terms used by previous authors in the field.  
 
We included subjective and objective outcome measures but in studies where survey 
instruments were employed we considered only those which used published validated 
measures. The primary outcome measure was key issues pertaining to quality of palliative 
and end of life care identified by people living with COPD and their families. We were 
interested to identify empirical research articles on the basis of population, intervention, 
outcomes, and study design (Box 1), a modified version of the PICOS (Population, 
Intervention, Comparator, Outcome, Study design approach16.   
 
We included only peer-reviewed research articles which reported on original research 
regardless of study type or country of origin but in the English language and published 
during the years (2015 -2017). Medical Subject Headings and free terms (see appendix I) 
were used to identify studies using the following databases: MEDLINE, EMBASE, CINAHL, 
CENTRAL and the University of Glasgow on-line Library. Articles meeting the inclusion 
criteria were downloaded into End Note and the full text of the articles obtained.  
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Quality appraisal 
Both authors appraised all full text articles using the relevant Critical Appraisal Skills 
Programme (CASP) questions17-20 to assess the quality of each study design. A scoring 
system was used that allowed the 10 CASP  criteria to be scored: 0 meaning criterion not 
fully addressed, 1 partially addressed and 2 the criterion was fully addressed. A total score 
between 15-20 or 20-26 when total 26 was considered high quality, whereas a score of 0-7 
was low quality.  Findings were recorded using a flowchart as with recommended practice 21 
(Fig. 1). Differences were resolved through consensus discussion and the results were 
tabulated (See Table 1). 
  
A total of 19 papers were included in the final review. The 19 included studies were 
conducted in 13 countries: Australia (n=2)22, 23; Canada, Denmark and Norway (n=1)24; 
Denmark (n=1)25; Germany (n=1)26; Greece (n=1)27; Italy (n=1)28; the Netherlands (n=1)29; 
New Zealand (n=1)30; Spain (n=2)31, 32; Sweden (n=1)33; United Kingdom (UK) (n=3)34-36; 
United States of America (USA) (n=3)37-39; USA and Germany40. The study designs comprised: 
randomised controlled trials (RCT) (n=3)22, 25, 34; systematic and literature reviews (n=3)24, 28, 
31; qualitative research studies (n=9)26, 27, 30, 32, 33, 35-37, 41; other studies - secondary analyses 
(n=3)29, 40, 42; retrospective observational studies (n=1)39.  
 
Data were analysed descriptively and the themes identified as most important in relation to 
the study aim are reported here: 1) Holistic Care; 2) Illness Trajectory; 3) Technology. 
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Holistic Care - Physical 
The importance of adopting a holistic approach to COPD caring was highlighted in the range 
of topics uncovered. These crossed several domains including physical, psychosocial and 
spiritual needs. Control of physical symptoms of COPD through optimising medicine use 
comprised the central focus of two studies 40, 42. Both studies analysed pooled data from 
earlier drug trials. Ferguson et al. (2017) sought to establish the efficacy of STIOLTO 
Respimat, a combination of two bronchodilators-tiotropium, and olodaterol, to address 
airway obstruction and breathlessness and improve long-term lung function. Outcomes 
showed that the new drug combination brought significant improvements in patients' 
quality of life, breathlessness and also reduced the use of night-time rescue medication. 
Ferreira et al. (2016) found that, in participants with chronic refractory breathlessness, and 
particularly in younger populations, there was a marked preference for morphine over 
placebo38. Inverse relationships were, however, found between morphine preference and 
sedation and between nausea and morphine preference. These results emphasise the 
clinical potential of morphine for symptom control in COPD but also demonstrate the need 
for a rigorous approach to combat negative side effects. 
 
A systematic review and meta-analysis evaluating the effectiveness of exercise training in 
patients with very severe COPD demonstrated functional improvements and enhanced 
health-related quality of life following exercise training 28. Prescriptions for supervised high 
intensity cycling or walking training with incremental testing to achieve optimum velocity 
are advocated as an important strategy to promote positive clinical change in this group of 
people. 
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Qualitative explorations on patient experiences and preferences of non-invasive ventilation 
(NIV) in chronic obstructive pulmonary disease in domiciliary35 and tertiary settings41 
illuminated the lack of convergence between health professional and patient perspectives 
on the purpose of, and need for, NIV. It emerged that patients felt under pressure to accept 
the recommendations of health professionals  to use NIV and that adaptation to continuing 
use, given the drawbacks of this treatment, was strongly influenced by the knowledge base, 
support levels of the health professionals  involved, and perceived concordance with their 
views35.  
 
Holistic Care - Psychosocial  
A randomised controlled trial comparing a minimal home based, nurse-led, psycho-
educative intervention based on comparing Cognitive Behavioural Therapy (CBT) to usual 
care proved acceptable to patients with COPD25. This was demonstrated through high 
compliance and sustained benefits over time shown through clinically significant changes in 
the Hospital Anxiety and Depression –subscale anxiety scores (HADS-A)43 post intervention 
compared with the control group. Findings were reinforced by the qualitative interview data 
but the transferability of the St. George Respiratory Questionnaire (SGRQ) to this Danish 
population was, however, uncertain due to the general lack of patient completion. 
 
A systematic review on relationships between COPD symptoms and disease burden across 
different life domains highlighted the need for improved recognition and understanding of 
the impact of COPD symptoms and burden 31. Long-term treatment plans incorporating 
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routine assessment of symptoms using patient-centred methods were advised to ensure 
effective 24 hour management. In similar vein, a secondary analysis of a longitudinal 
observational study on caregiver burden and the positive aspects of caregiving exposed the 
changeable and highly individual nature of caregiver burden29. The need for healthcare 
professioanls to pay regular attention to the particular needs of family caregivers, regardless 
of the patients' characteristics, was raised as a key facet of family-based care. 
 
The importance of undertaking key conversations to establish the personal preferences of 
patients and to provide relevant and timely information on COPD was a recurrent theme. 
Studies referring to Advance Care Planning (ACP) revealed that patients commonly evade 
discussing their prognosis and difficult topics relating to COPD23. The challenges of such 
conversations were evident both between patients and family members and between both 
patients and family members and health professionals. The findings demonstrated that, 
although, the majority of people with COPD prefer to not undergo cardiopulmonary 
resuscitation (CPR), in the main, the issue is not discussed with health professionals 41.  A 
recent retrospective review of medical records following a successful trial intervention to 
increase the incidence of end-of-life conversations showed that the primary outcome was 
not associated with a higher percentage of patients with documented unique end-of-life 
care conversations or completion of advance care directives compared to the control 
group39.   
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Holistic Care - Spiritual  
A qualitative interview study was undertaken to understand Greek COPD patients’ 
perceptions of spirituality and religiosity and to explore the importance of practising their 
belief 27. The authors described a lack of attention to religious and spiritual needs in the 
context of clinical care, despite the fact that the majority of participants (84%) expressed 
religious and/or spiritual beliefs. Faith in the will of God and the importance of praying and 
church attendance featured strongly as a supportive factor in patient coping with COPD but 
functional limitations of the illness created a barrier to regular churchgoing, raising 
important issues about unmet need in this area. 
 
Illness Trajectory - Uncertainty and loss/ Timing of interventions 
Key patterns in the illness trajectory of advancing COPD were identified by several authors 
26, 30, 32-34. These emphasise the unpredictable nature of COPD illness progression 
accompanied by resultant uncertainty and feelings of disempowerment experienced by 
patients and carers.  Although acute episodes are often succeeded by an improvement in 
the condition and ongoing survival the intense nature of these exacerbations  often 
intensifies the fear of death33. Interestingly, panic attacks, not breathlessness have been 
purported as markers of advanced disease although the feeling nature of adverse 
psychological experiences are often not openly shared by patients30, 32. Reduction in 
mobility and social exclusion exert increasing influence on core illness experience with 
patients and carers describing feelings of being at the mercy of the illness whilst striving to 
maintain some semblance of normality 26. The roller coaster experience of the COPD illness 
trajectory can lead to emotional exhaustion and continual worry about the future. Recent 
evidence strongly points to the need for better case management to help families prepare 
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for uncertainty and to more effectively address the physical, psychosocial and spiritual 
needs of patients26, 30, 32-34.  Transition points and specific triggers such as hospital admission 
have been spotlighted as potentially useful entry points for conducting holistic needs 
assessment 32, 34, 41.  
 
Findings also, however, emphasise challenging issues relating to acceptance of professional 
support. It appears that, from the patient perspective, current treatments (including rescue 
medication) can provide effective symptom management over a sustained period until the 
point of physical incapacity is reached26. The efficacy of acute care interventions and 
treatment regimes in the earlier and intermediate stages of COPD bring security 30. 
Paradoxically, this can foster misunderstandings about future prognosis that can impair 
coping with end stage experience when physical deterioration is associated with a marked 
drop in mental and social wellbeing26.  
 
Recent qualitative research identified the inadequacy of information given to patients and 
carers resulting in uncertain knowledge and the formulation of interpretations about COPD 
that tend to either minimise its severity or exacerbate worry26, 32, 44. The need for positive 
communication including lay explanations on definitions, cause, process and incurability of 
COPD is recommended to help improve patient understanding of the illness 26, 32, 35. 
Providing health promotion that does not promote assignation of responsibility (smoking 
cessation advice often promotes feelings of responsibility yet patients are reluctant to 
accept this) requires sensitivity and skill 26, 32. The advance of COPD is unremitting and 
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lifestyle changes often occur too late to make a difference to life quality, highlighting, the 
need for timely intervention.  
Technology 
Stakeholder perspectives on developing a Web-based advance care planning tool for lung 
disease showed that this was a potentially useful and acceptable means of care provision37. 
Patients suggested that the use of videos of medical scenarios and patient narratives would 
be preferable to textual information. Patients liked the concept of interactive content that 
was under their own control so they could decide how much to complete in a single sitting. 
Participants also identified challenges and potential solutions, such as how to manage the 
emotional difficulty of thinking about death and accommodate low computer literacy users. 
 
The usefulness of the Health Information Technology Acceptance Model (HITAM) for 
understanding acceptance of Health Information Technology (HIT) was examined in a RCT 
for older people with COPD and associated heart diseases (CHROMED)36. Results showed 
that self-management of HIT was linked to a good organisational framework, ergonomics 
and informal, accessible support.  Drawbacks were associated with patient concerns about 
less face-to-face health professional contact and heightened illness anxiety through the 
more frequent monitoring of health status. The perceived usefulness of HIT was related to 
establishing trends in health status, detecting early signs of infection and potential to self-
manage, all health professional driven outcomes.  
 
A recent pilot trial examined the effects of home tele-monitoring (TM) of patients with 
severe chronic obstructive pulmonary disease (COPD) 22. TM appeared to delay the 
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incidence of COPD-related exacerbations requiring a hospital visit and to reduce the level of 
COPD-related emergency presentations at hospitals, subsequent admissions to hospital and 
the length of in-patient stays. Collectively, these improvements were noted to have a 
beneficial impact on the costs of hospital care. TM was perceived to be accepted by most 
patients and nursing staff but positive impacts were confined to physical well-being 
outcomes. Caution needs to be applied to conclusions from this study due to the small 
sample size and high attrition. The  
Discussion 
This review has highlighted recent positive developments in the care and treatment for 
people living with advanced COPD. Advances in drug treatment, exercise therapy and 
psychological interventions have been shown to promote well-being and quality of life. The 
role of technology also shows promise but the benefits of this require further investigation 
to ascertain how this can best be utilised to emphasise patient rather than professional 
benefit.  
An important sub-theme of this review was the lack of congruence in some relationships 
between health care professional and patients/carers signalling the need for more in-depth 
and timely conversations about the nature of COPD, its progression, prognosis and 
treatment options. Authors here have highlighted a reluctance on the part of health 
professionals to engage in discussions about sensitive issues and the need for improved 
education and training to inform and facilitate these23, 26, 30, 35, 44. Where work has been 
undertaken to remedy these factors, insufficient documentation may have resulted in a 
failure for patient wishes to be upheld, negating the potential of initial benefits39. 
Furthermore, it has been indicated that, there is a need to assess the quality of existing care 
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prior to the introduction of new interventions to prevent duplication and promote 
harmonisation of care22, 34.  
The fluctuating and unpredictable nature of chronic respiratory illness suggests the benefits 
of ongoing holistic assessment commenced at an earlier stage in the disease trajectory.  The 
evidence here indicates, however, that people do not often not desire of professional input 
and wish to maintain personal autonomy over their illness management even when 
significant symptom burden is present26, 30, 34. The issue of perceived patient resistance to 
early professional intervention requires further investigation to establish whether it is the 
nature of professional inputs that are the problem rather than a patient reluctance to 
explore difficult issues. The research reported here exemplifies that models of care need to 
be closely informed by patients and focus on maintaining normality for as long as possible. 
Dealing with a terminal illness can elicit feelings of vulnerability and lack of autonomy45 with 
the failure to express unmet care needs a key issue for attention in respect of end of life 
care 46-49.  Optimal palliative and end of life care interventions facilitate patient preferences 
on care practices and choice of place of death 4, 5, 50 but the need for expert knowledge and 
understanding of particular disease processes and treatments is a key facet in supporting 
patient acceptability choice. 
 
The increased use of home-based brief interventions that encompass holistic assessment 
may indicate a useful opportunity for developing closer relationships with patients and 
carers. These can provide continuity of care through monitoring patient and carer status 
throughout the different disease milestones whilst offering judicious and discreet psycho-
social support. This approach may also help to open channels of communication for deeper 
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conversations about end of life and related issues and points to the role of trained 
community workers, especially nurse specialists. 
 
Limitations 
Due to time restrictions we did not search all relevant databases or search the grey 
literature. In carrying out a modified search we may have failed to identify additional 
articles and other material such as unpublished conference abstracts, policy documents, and 
technical reports. Neither did we search for study protocols of RCTs in process or contact 
any of the primary authors. Our focus was specifically on the care needs of people living 
with advanced COPD and their families thus we excluded a number of studies that are of 
relevance to earlier stages of this condition. The descriptive analysis offers an overview of 
the current literature rather than the increased critical precision provided by a full 
systematic review with meta-analyses or meta-syntheses. Finally, findings represent a global 
spread of nations but these are all developed countries with advanced health systems thus, 
although greater homogeneity may be indicated, insights are restricted to these domains.  
 
Conclusion:   
Illness trajectories highlight the changing pattern of COPD illness progression and emphasise 
a range of unmet needs. Early interventions of palliative care are proposed by policy makers 
and supported by health professionals but getting the timing and the ingredients right is a 
key factor. Care interventions need to be based on patient preferences rather than 
professionally driven. Positive findings in respect of the STIOLTO Respimat inhaler are 
encouraging. Psychosocial interventions exercise, and the prudent use of technology also 
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convey promise but the limited research in people with advanced disease calls for further 
studies to confirm the value of these approaches.  
 
 
Key points:  
 Despite positive intentions a lack of converging attitudes between health care 
professional perspectives and patients/carers means that the concept of holistic care 
remains an ideal rather than a reality with areas of unmet need emphasised across 
physical, psycho-social and spiritual domains. 
 Positive developments in the care and treatment of advanced COPD include the use 
of the STIOLTO Respimat inhaler, a brief educative and psychosocial intervention 
based on cognitive-behavioural therapy, and high intensity exercise training. 
 There is mixed evidence of patient benefit, especially in respect of improved 
autonomy, from the use of technology in end stage COPD but this approach can be 
maximised through patient and carer involvement in the design, development and 
delivery of interventions. 
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